EA201290948A1 - МАРКЕРЫ HbF И A1M В КАЧЕСТВЕ МАРКЕРОВ РАННЕЙ СТАДИИ ПРЕЭКЛАМПСИИ - Google Patents

МАРКЕРЫ HbF И A1M В КАЧЕСТВЕ МАРКЕРОВ РАННЕЙ СТАДИИ ПРЕЭКЛАМПСИИ

Info

Publication number
EA201290948A1
EA201290948A1 EA201290948A EA201290948A EA201290948A1 EA 201290948 A1 EA201290948 A1 EA 201290948A1 EA 201290948 A EA201290948 A EA 201290948A EA 201290948 A EA201290948 A EA 201290948A EA 201290948 A1 EA201290948 A1 EA 201290948A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hbf
lampsia
markers
marker
early stage
Prior art date
Application number
EA201290948A
Other languages
English (en)
Other versions
EA024188B1 (ru
Inventor
Бо Акерстрем
Магнус Ольссон
Стефан Ханссон
Original Assignee
Прилумина Дайагностикс Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Прилумина Дайагностикс Аб filed Critical Прилумина Дайагностикс Аб
Publication of EA201290948A1 publication Critical patent/EA201290948A1/ru
Publication of EA024188B1 publication Critical patent/EA024188B1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Measuring Temperature Or Quantity Of Heat (AREA)

Abstract

Способ диагностики или прогнозирования риска развития преэклампсии с помощью измерения уровня A1M и одного или нескольких из соединений HbA, HbF в образце и сравнения полученных данных с референсными значениями. С помощью комбинированной информации, относящейся к A1M и HbF, наблюдали улучшение диагностики или прогнозирования.
EA201290948A 2010-03-24 2011-03-24 МАРКЕРЫ HbF И A1M В КАЧЕСТВЕ МАРКЕРОВ РАННЕЙ СТАДИИ ПРЕЭКЛАМПСИИ EA024188B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201000245 2010-03-24
PCT/EP2011/001458 WO2011116958A1 (en) 2010-03-24 2011-03-24 Hbf and a1m as early stage markers for preeclampsia

Publications (2)

Publication Number Publication Date
EA201290948A1 true EA201290948A1 (ru) 2013-04-30
EA024188B1 EA024188B1 (ru) 2016-08-31

Family

ID=42829834

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201290948A EA024188B1 (ru) 2010-03-24 2011-03-24 МАРКЕРЫ HbF И A1M В КАЧЕСТВЕ МАРКЕРОВ РАННЕЙ СТАДИИ ПРЕЭКЛАМПСИИ

Country Status (20)

Country Link
US (1) US20130122529A1 (ru)
EP (1) EP2550535B1 (ru)
JP (1) JP5926722B2 (ru)
KR (1) KR20130012023A (ru)
CN (1) CN102906568B (ru)
AU (1) AU2011231982B2 (ru)
BR (1) BR112012024175A2 (ru)
CA (1) CA2794021C (ru)
DK (1) DK2550535T3 (ru)
EA (1) EA024188B1 (ru)
ES (1) ES2543171T3 (ru)
HK (1) HK1179694A1 (ru)
HR (1) HRP20150802T1 (ru)
HU (1) HUE027719T2 (ru)
MX (1) MX2012011007A (ru)
NZ (1) NZ602733A (ru)
PL (1) PL2550535T3 (ru)
PT (1) PT2550535E (ru)
WO (1) WO2011116958A1 (ru)
ZA (1) ZA201207902B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2111555E (pt) 2007-02-12 2013-09-04 A1M Pharma Ab Diagnóstico de pré-eclâmpsia
RU2568891C1 (ru) * 2014-08-28 2015-11-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии на основе комбинаций генов цитокинов
RU2568893C1 (ru) * 2014-09-04 2015-11-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии у женщин с неотягощенной наследственностью
JP2016173366A (ja) 2015-03-16 2016-09-29 エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ 子癇前症のバイオマーカー
KR102345905B1 (ko) 2015-07-30 2021-12-30 삼성전자주식회사 분광기의 반복 재현성 검증 장치 및 방법, 스펙트럼 데이터 분석 장치

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079171A (en) 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
US5238819A (en) 1988-12-14 1993-08-24 The Regents Of The University Of California Diagnostic assay for the detection of preeclampsia
US5939272A (en) * 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5108898A (en) 1989-01-18 1992-04-28 Peters John H Use of fibronectin having a variable included type III repeat sequence as a marker for toxemia in pregnancy
DE60235416D1 (de) * 2001-05-04 2010-04-01 Biosite Inc Diagnostische Marker der akuten koronaren Syndrome und ihre Verwendungen
GB0308967D0 (en) * 2003-04-17 2003-05-28 Univ London Screen for pre-eclampsia
WO2005093413A2 (en) 2004-03-22 2005-10-06 Yale University Diagnosis and treatment of preeclampsia
US20060105419A1 (en) * 2004-08-16 2006-05-18 Biosite, Inc. Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions
US20100190192A1 (en) * 2005-09-15 2010-07-29 Victor Voroteliak Method of diagnosing pre-eclampsia
US20080133141A1 (en) * 2005-12-22 2008-06-05 Frost Stephen J Weighted Scoring Methods and Use Thereof in Screening
GB0600916D0 (en) * 2006-01-17 2006-02-22 Perkinelmer Instr Las Inc detecting and predicting pre-eclampsia
CN101416060A (zh) * 2006-02-02 2009-04-22 诊断技术有限公司 用于确定先兆子痫治疗有效性的方法
CA2654283A1 (en) * 2006-05-31 2008-03-13 Beth Israel Deaconess Medical Center, Inc. Methods of diagnosing and treating complications of pregnancy
PT2111555E (pt) * 2007-02-12 2013-09-04 A1M Pharma Ab Diagnóstico de pré-eclâmpsia
WO2009108073A1 (en) * 2008-02-28 2009-09-03 Auckland Uniservices Limited Biomarkers for prediction of preeclampsia and/or cardiovascular disease

Also Published As

Publication number Publication date
AU2011231982B2 (en) 2014-02-20
CN102906568B (zh) 2014-11-12
HK1179694A1 (en) 2013-10-04
CA2794021C (en) 2018-03-13
DK2550535T3 (en) 2015-07-27
BR112012024175A2 (pt) 2016-07-05
EP2550535A1 (en) 2013-01-30
HUE027719T2 (en) 2016-10-28
NZ602733A (en) 2014-03-28
AU2011231982A1 (en) 2012-10-25
JP2013522634A (ja) 2013-06-13
JP5926722B2 (ja) 2016-05-25
US20130122529A1 (en) 2013-05-16
CA2794021A1 (en) 2011-09-29
EP2550535B1 (en) 2015-05-06
EA024188B1 (ru) 2016-08-31
WO2011116958A1 (en) 2011-09-29
MX2012011007A (es) 2013-03-20
ES2543171T3 (es) 2015-08-17
PL2550535T3 (pl) 2015-09-30
ZA201207902B (en) 2014-03-26
PT2550535E (pt) 2015-09-07
KR20130012023A (ko) 2013-01-30
HRP20150802T1 (en) 2015-11-06
CN102906568A (zh) 2013-01-30

Similar Documents

Publication Publication Date Title
EA201590027A1 (ru) Способы детекции заболеваний или состояний
EA201270020A1 (ru) Определение риска развития атеросклеротической болезни сердца
WO2014020502A3 (en) Markers associated with sensitivity to inhibitors of human double minute 2 (mdm2)
EA201690213A1 (ru) Композиции и способ лечения связанных с комплементом состояний
MX367046B (es) Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
MX2015006680A (es) Composiciones y metodos para diagnosticar tumores de tiroides.
EA201290311A1 (ru) Факторы риска и прогнозирование инфаркта миокарда
EP4361609A3 (en) Signal encoding and decoding in multiplexed biochemical assays
MX363201B (es) Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico.
BR112012030587A2 (pt) métodos para diagnóstico de câncer pancreático, para identificar se um indivíduo precisa ou não de uma terapia contra câncer pancreático e para determinar se uma terapia contra câncer pancreático obtém sucesso, dispositivo para diagnóstico de câncer pancreático e uso de pelo menos um biomarcador
EA201391245A1 (ru) Интеррогативные клеточные анализы и их применение
WO2012096545A3 (ko) 췌장암 암줄기세포 특성을 이용한 췌장암 신규 바이오마커 및 그의 용도
EA201490533A1 (ru) Способы и композиции для определения статуса в отношении курения
CY1122360T1 (el) Μεθοδος για τη διαγνωση της νοσου niemann-pick
EA201370063A1 (ru) Фосфолипидом рака
EA201290948A1 (ru) МАРКЕРЫ HbF И A1M В КАЧЕСТВЕ МАРКЕРОВ РАННЕЙ СТАДИИ ПРЕЭКЛАМПСИИ
WO2012082742A3 (en) Detecting cancer with anti-ccl25 and anti-ccr9 antibodies
WO2013106844A3 (en) Methods and compositions for the treatment and diaginosis of pancreatic cancer
WO2014053996A3 (en) Antibodies to microbiome, stress factors and mast cell markers as diagnostic markers for ibs
BR112016002668A2 (pt) métodos e kits para prognosticar o risco de ter uma doença ou evento cardiovasculares
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
MX336940B (es) Uso de compuestos mejoradores de señal en deteccion de electroquimioluminiscencia.
WO2013062261A3 (en) Newly identified colon cancer marker and diagnostic kit using the same
WO2012042228A3 (en) Method and system for determining characteristics of an embryo and uses thereof
BR112014014279A2 (pt) método para obter dados úteis para o diagnóstico e/ou prognóstico de insuficiência renal aguda; uso de pelo menos um micro-rna; kit para o diagnóstico e/ou prognóstico de insuficiência renal aguda e uso do kit

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU